Author:
Nam Jehyun,Kim Dong Uk,Kim Eungyoung,Kwak Bomi,Ko Min Ji,Oh Ah-Young,Park Bum-Joon,Kim Yea Woon,Kim AeRi,Sun Hokeun,Jung Youngmi,Lee Jae-Hoon,Shin Ho-Jin,Park Inmyoung,Song Dae-Kyu,Jeong Jee-Yeong,Lee Yun-Han,Kim Sang-Woo
Funder
National Research Foundation of Korea
Youngsan University
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference47 articles.
1. Ott G. Impact of MYC on malignant behavior. Hematol Am Soc Hematol Educ Program. 2014;2014:100–6.
2. Dang CV. MYC on the path to cancer. Cell. 2012;149:22–35.
3. Eilers M, Eisenman RN. Myc’s broad reach. Genes Dev. 2008;22:2755–66.
4. Sewastianik T, Prochorec-Sobieszek M, Chapuy B, Juszczynski P. MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications. Biochim Biophys Acta. 2014;1846:457–67.
5. Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011;146:904–17.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献